Trial Profile
Efficacy and tolerability of cannabidiol in paediatric patients with epilepsy.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 03 Jan 2018
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy
- Focus Expanded access; Pharmacodynamics
- 03 Jan 2018 New trial record
- 05 Dec 2017 Results assessing effect of Cannabidiol on cortical excitability presented at the 71st Annual Meeting of the American Epilepsy Society